ARTICLE | Clinical News
Lidak regulatory update
July 17, 1995 7:00 AM UTC
LDAKA received notices of allowance for three patents. One allowed patent covers LDAKA's Severe Combined ImmunoDeficiency (SCID) mouse model, which transplants human immune cells into immunologically ...